Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controlsDavid G. Standaert, Andy Singleton, Mark Frasier et al.|Neurology|2017Cited by 152
Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficitsNorbert Schuff, Kenneth Marek, I‐Wei Wu et al.|Movement Disorders|2015Cited by 59
Safety and efficacy of N-acetylmannosamine (ManNAc) in patients with GNE myopathy: an open-label phase 2 studyNuria Carrillo, William A. Gahl, May Christine V. Malicdan et al.|Genetics in Medicine|2021Cited by 55